Loss of libido in menopausal women. Management issues.

Aust Fam Physician

Jean Hailes Medical Centre for Women, Jean Hailes Foundation, Melbourne, Victoria.

Published: May 2002

Background: Due to a complex interplay of sociocultural factors, past experiences, relationships and hormones, a woman's experience at menopause and beyond is highly individual. A variety of external, often stressful, life events can be occurring at this time in a woman's life, all impacting on her individual symptom profile. Menopause is a natural event in a woman's life cycle and loss of libido may be one of a multitude of symptoms experienced around this time. In fact, the decline in sexual interest commonly precedes the onset of a natural menopause, even though many women do not report their loss of libido until the menopause, when symptoms may be exacerbated.

Objective: To review contributing factors and treatment options available for menopausal women experiencing loss of libido.

Discussion: With increasing awareness, knowledge and discussion about sexual health issues, there are an increasing number of women seeking advice and treatment for low libido. The introduction of the oral contraceptive pill in the '60s; the increasing use of HRT for menopausal symptoms; the availability of drugs such as sildenafil; the recent acknowledgement and definition of the 'female androgen insufficiency syndrome' are all factors which have contributed to the so-called 'sexual revolution' whereby women and their doctors--are able to feel more comfortable discussing their sexual concerns. Nevertheless, many women will not volunteer this information and it is advisable to specifically ask about libido and associated symptoms of mood and well being.

Download full-text PDF

Source

Publication Analysis

Top Keywords

loss libido
12
menopausal women
8
woman's life
8
women
6
loss
4
libido menopausal
4
women management
4
management issues
4
issues background
4
background complex
4

Similar Publications

Background: Giant prolactinoma (size > 4 cm) is a rare condition and accounts for less than 1% of pituitary adenomas. In even rarer cases, these lesions may involve craniocervical structures requiring surgical intervention. The present case is the largest reported giant prolactinoma (99 × 72 × 57 mm).

View Article and Find Full Text PDF

Lipid-lowering therapy (LLT) includes a diverse group of pharmaceuticals designed to reduce blood levels of cholesterol and triglyceride (TG), helping to prevent cardiovascular diseases like myocardial infarction and stroke. LLT includes treatment with several lipid-lowering drugs (LLD), including hydroxymethylglutaryl (HMG-CoA) reductase inhibitors (statin), PCSK9 Inhibitors, cholesterol-absorbing inhibitors (Ezetimibe), Bile Acid Sequestrants, Fibrates, Niacin (Vitamin B3), Omega-3 Fatty Acids, Bempedoic Acid, and combination therapy. The efficacy and safety of these molecules vary widely.

View Article and Find Full Text PDF

We report the case of a 39-year-old patient who complains about loss of libido and erectile dysfunction. Hormonal diagnosis revealed hypergonadotropic hypogonadism suggesting a primitive testicular cause. Testicular examination, testicular ultrasounds and abdomen-pelvis CT scan made it possible to suspect a right testicular tumor.

View Article and Find Full Text PDF

Systematic Review and Meta-Analysis of Female Reproductive Health Following Ebola Virus Disease.

Am J Trop Med Hyg

December 2024

Department of Medicine, Section of Infectious Diseases, School of Medicine, Tulane University, New Orleans, Louisiana.

Article Synopsis
  • The systematic review focuses on reproductive health issues faced by female survivors of Lassa fever and Ebola virus disease.
  • Thirteen studies reviewed predominantly highlight negative outcomes related to reproductive health among EVD survivors, including menstrual irregularities and pregnancy loss, with no research identified on LF survivors.
  • The analysis indicates that about 14% of female EVD survivors experience adverse reproductive health outcomes, revealing a significant need for further research in this area.
View Article and Find Full Text PDF

Male-typical behaviors such as aggression and mating, which reflect sexual libido in male mice, are regulated by the hypothalamus, a crucial part of the nervous system. Previous studies have demonstrated that microRNAs (miRNAs), especially , play a vital role in reproduction and the neural control of behaviors. However, it remains unclear whether affects reproduction through the hypothalamus-mediated regulation of male-typical behaviors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!